| pubmed-article:15261273 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15261273 | lifeskim:mentions | umls-concept:C0031397 | lld:lifeskim |
| pubmed-article:15261273 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:15261273 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:15261273 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:15261273 | lifeskim:mentions | umls-concept:C0681840 | lld:lifeskim |
| pubmed-article:15261273 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:15261273 | pubmed:dateCreated | 2004-7-20 | lld:pubmed |
| pubmed-article:15261273 | pubmed:abstractText | Inhibitors of phenylethanolamine N-methyltransferase [PNMT, the enzyme that catalyzes the final step in the biosynthesis of epinephrine (Epi)] may be of use in determining the role of Epi in the central nervous system. Here we demonstrate that a routinely used assay for screening PNMT inhibitors is not appropriate for those inhibitors having K(i) values less than 1 microM. A revised assay has been developed that shows some inhibitors bind two orders of magnitude more tightly than previously reported. | lld:pubmed |
| pubmed-article:15261273 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15261273 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15261273 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15261273 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15261273 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15261273 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15261273 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15261273 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15261273 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:15261273 | pubmed:author | pubmed-author:McLeishMichae... | lld:pubmed |
| pubmed-article:15261273 | pubmed:author | pubmed-author:GrunewaldGary... | lld:pubmed |
| pubmed-article:15261273 | pubmed:author | pubmed-author:WuQianQ | lld:pubmed |
| pubmed-article:15261273 | pubmed:author | pubmed-author:CriscioneKevi... | lld:pubmed |
| pubmed-article:15261273 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15261273 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:15261273 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:15261273 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15261273 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15261273 | pubmed:pagination | 4217-20 | lld:pubmed |
| pubmed-article:15261273 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15261273 | pubmed:meshHeading | pubmed-meshheading:15261273... | lld:pubmed |
| pubmed-article:15261273 | pubmed:meshHeading | pubmed-meshheading:15261273... | lld:pubmed |
| pubmed-article:15261273 | pubmed:meshHeading | pubmed-meshheading:15261273... | lld:pubmed |
| pubmed-article:15261273 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15261273 | pubmed:articleTitle | Phenylethanolamine N-methyltransferase inhibition: re-evaluation of kinetic data. | lld:pubmed |
| pubmed-article:15261273 | pubmed:affiliation | College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109, USA. | lld:pubmed |
| pubmed-article:15261273 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15261273 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:15261273 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15261273 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15261273 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15261273 | lld:pubmed |
